Posts

BRDX — Warrant Overhang Watching for the Next Big Bang

BDRX: The Bullish Retest ACCUMULATION ZONE: $3.25 - $3.40 The market is currently digesting the 1-for-5 reverse ADR split (effective April 6). While the 14% drop from yesterday's close looks aggressive, the data reveals a textbook "Gap-Fill & Go" setup. Today’s light-volume drift is likely a shakeout of weak hands before the next leg of the Syngene-backed rally . Last Trade $3.32 Warrant Floor $3.28 Market Cap $10.9M Rel. Vol ~200K 1. Post-Split Price Plan (5x Adjusted) Every level from our April 2nd breakout thesis remains valid when scaled by the 5x split multiplier. We are currently sitting at the very edge of the "Momentum Entry" zone. Phase Pre-Split Target ...
Post a Comment
Read more

Break on Through — Casino Time 🎰

IMPORTANT LEGAL DISCLAIMER: This report is for educational and informational purposes only. Trading stocks, options, and futures involves substantial risk of loss and is not suitable for every investor. The "probabilities" mentioned are based on historical patterns and are not guarantees of future performance. I am not a financial advisor. Please consult with a licensed professional before making any investment decisions. Weekend Casino Breakout Report – Technical Tables Edition Published: April 5, 2026 High-Probability Brink Setups with Entry/Exit/Return/Probability Tables Here are clean, easy-to-read tables for every setup from the report (ASTS, BDRX, NVDA, TSLA, PLTR, HOOD, CL/oil, AA, KELYB). All levels use April 2, 2026 closes + fresh technical data. BDRX Note: 1-for-5 reverse split effective Monday April 6—tables show pre-split prices; % returns unchanged post-split. $ASTS – Top Pick (Failed Breakdown in Ascending Channel...
Post a Comment
Read more

BDRX

BDRX Watchlist Notes - April 2, 2026 BDRX (Biodexa Pharmaceuticals) - My Watchlist Notes April 2, 2026 Huge volume surge today – still on my radar What Happened Today I’ve been watching BDRX for a while, and today it finally delivered a big move I’ve been hoping for after a long downturn. The stock closed at $0.8733 , up +42.23% on massive volume of \~120 million shares. It hit a high of $1.35 intraday with very little retracement during the session. Catalyst: Fresh news this morning – Biodexa partnered with Syngene International to manufacture GMP clinical trial supplies of MTX240 . Read the official press release here . My Take on the Move This doesn’t feel like a dead-cat bounce. Today’s explosion came with legitimate news, extreme volume, and...
Post a Comment
Read more

ONCO — On The Radar

ONCO (Onconetix, Inc.) Trading Notes Date: April 1, 2026 (Post-Market Close) Price: $1.875 ▲ +0.385 (+25.85%) Volume: 2.61M (Avg: 1.30M) Quick Take: Nice momentum day on the fresh CEO appointment and ongoing Realbotix humanoid robotics / 6G buzz. Low float (~656K) makes it explosive but extremely risky. Classic micro-cap swing setup after the 1-for-5 reverse split. 📊 Key Snapshot Metric Value Market Cap ~$1.34M Shares Outstanding ~716.85K Float ~655.94K 52-Week Range $1.17 – $74.29 P/B Ratio 0.0371 📈 Game Plan & Indicators Indicator Status Entry Signal RSI (14) ~50-52 (Neutral) Pullback to 40-45 or hold 50 S...
Post a Comment
Read more

NTLA On The Radar

NTLA Trading Notes - April 2026 NTLA (Intellia Therapeutics) - Trading Notes Updated: Early April 2026 | CRISPR Gene Editing Biotech | Focus: lonvo-z (HAE) & nex-z (ATTR) Quick Market Snapshot Recent Price: ~$12.80 – $13.50 (closed ~$12.82 on Mar 31, +10% on high volume; volatile with recent +3–10% days). Market Cap: ~$1.5B | 52-Week Range: ~$5.90 – $28.25. Key Catalysts: HAELO Phase 3 topline data mid-2026 ; ATTR MAGNITUDE trial resumption post-FDA hold lift with enhanced liver monitoring. Analyst View: Moderate Buy, avg. PT ~$19–$25 (upside ~50–90% from current levels). Indicators to Watch for NTLA Events Fundamental/catalyst indicators drive big moves; technicals help with timing entries/exits. 1. Fundamental & Catalyst Indicators ...
Post a Comment
Read more

How low can you Zillow

Disclaimer: This analysis is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves significant risk. Data is based on market conditions as of March 2026. Always conduct your own due diligence before making any investment decisions. Zillow (Z) Investment Thesis: March 2026 As of March 27, 2026, Zillow (Z) closed at $40.44 , hovering near its 52-week low. Following a sharp pullback from its 2025 highs, the setup presents a classic "value-recovery" play backed by aggressive corporate action. $40.44 Current Price $1.25B New Buyback Auth. 3.7x TTM Sales Multiple ~30% Rentals Growth View Z Chart on TradingView → The Catalyst Mix Massive Buyback Signal: On Ma...
Post a Comment
Read more

Last April Weekend Report

Weekend Market Scan: Hunting Higher-Probability Setups for the Short Week Ahead March 31 – April 3, 2026 The broader tape remains volatile and deeply oversold heading into a holiday-shortened week. Geopolitical tensions from the ongoing U.S.–Iran conflict continue to dominate sentiment, with oil swinging on ceasefire headlines and risk-off pressure weighing on indices. The S&P 500 and Nasdaq have pulled back sharply, with the Nasdaq officially in correction territory. Oversold technical readings (RSI levels not seen in recent cycles) raise the odds of a short-term relief bounce or exhaustion move. With a relatively light economic calendar and only selective earnings in focus, conditions may favor tactical, high-probability swing setups. 📌 Key Catalyst to Watch Nike (NKE) reports Q3 fiscal 2026 results after the close on Tuesday, March 31. Expectations are muted, but a beat or constructive guidance could spark...
Post a Comment
Read more